III Steering Committee Meeting. Mexico, DF. May 2003. Annex 4. Bioequivalence Working Group. J. Molzon

III Steering Committee Meeting. Mexico, DF.  May 2003.  Annex 4. Bioequivalence Working Group. J. Molzon

31 p.

Justina A. Molzon, M.S. Pharm., J.D. Associate Director for International Affairs Center for Drug Evaluation and Research/USFDA